Gideon Capital Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,743
Closed -$465K 363
2018
Q4
$465K Buy
+15,743
New +$580K 0.19% 169
2018
Q3
Sell
-13,800
Closed -$568K 337
2018
Q2
$568K Buy
+13,800
New +$628K 0.28% 110
2017
Q4
Sell
-10,077
Closed -$512K 292
2017
Q3
$512K Buy
10,077
+2,514
+33% +$134K 0.5% 42
2017
Q2
$438K Sell
7,563
-6,646
-47% -$386K 0.48% 69
2017
Q1
$831K Buy
14,209
+4,536
+47% +$257K 0.49% 32
2016
Q4
$538K Buy
+9,673
New +$517K 0.34% 72
2014
Q4
Sell
-13,579
Closed -$582K 209
2014
Q3
$582K Buy
+13,579
New +$609K 0.23% 136

Other funds holding ALKS

Gideon Capital Advisors's ALKS Position: Q1 2019 in Review

Gideon Capital Advisors sold out of Alkermes (ALKS) in Q1 2019, closing a stake of 15,743 shares — an estimated $465K sold.

Gideon Capital Advisors first reported a position in ALKS in Q3 2014 and held it in 7 quarters. The position peaked at $831K in Q1 2017. 220 funds tracked by Wall St. Rank hold ALKS as of Q1 2019.

  • Gideon Capital Advisors reported no remaining Alkermes position as of Q1 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 15,743 Alkermes shares in Q1 2019, an estimated $465K.
  • Gideon Capital Advisors first reported a position in Alkermes in Q3 2014 and held it in 7 quarters.
  • Gideon Capital Advisors's Alkermes position peaked at $831K in Q1 2017.
  • 220 funds tracked by Wall St. Rank held Alkermes as of Q1 2019.

Based on Gideon Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.